NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 80 filers reported holding NEXTCURE INC in Q2 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 46 | +318.2% | 0.00% | – |
| Q1 2023 | $0 | – | 11 | -93.5% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 169 | -15.5% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -83.3% | 200 | -69.0% | 0.00% | – |
| Q2 2021 | $6,000 | -60.0% | 646 | -56.1% | 0.00% | – |
| Q1 2021 | $15,000 | +275.0% | 1,471 | +301.9% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 366 | +64.1% | 0.00% | – |
| Q3 2020 | $2,000 | -60.0% | 223 | -5.1% | 0.00% | – |
| Q2 2020 | $5,000 | -50.0% | 235 | -11.7% | 0.00% | – |
| Q1 2020 | $10,000 | -9.1% | 266 | +33.0% | 0.00% | – |
| Q4 2019 | $11,000 | +57.1% | 200 | -14.2% | 0.00% | – |
| Q3 2019 | $7,000 | +133.3% | 233 | +16.5% | 0.00% | – |
| Q2 2019 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |